Auf dieser Seite
ANAB AnaptysBio, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Mai 12, 2026
$48,53
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$29,4852-Wochen-Tief
$73,3052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.41B
P/E (TTM)
-47.6
EPS (TTM)
$-1.02
Umsatz (TTM)
$232M
Ihre Abzeichen
52W-Spanne
$29–$73
Analystenbewertung
BUY
Kursziel
$87
P/E
-47.6
ROE
-114.6%
Nettogewinnmarge
-11.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ANAB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$48.53
Marktkapitalisierung (MRQ)
$1.41B
P/E (TTM)
-47.6
EPS (TTM)
$-1.02
Umsatz (TTM)
$232M
ROE (TTM)
-114.6%
52W-Spanne
$29–$73
ANAB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 20. April 2026 | 3-for-2 | Vorwärts |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$235M2016-12-31 → 2025-12-31
EPS$-0.462016-12-31 → 2025-12-31
Freier Cashflow·2018-12-31 → 2024-12-31
Nettogewinnmarge-11.5%2018-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ANAB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -47.65-Jahres-Durchschnitt ≈-27.0 | ≈-27.0 | · | · | |
| P/S (TTM) | 6.15-Jahres-Durchschnitt ≈34.7 | ≈34.7 | 11.4 | Unterbewertet | |
| K/B (MRQ) | 110.55-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 3.1 | Überbewertet | |
| Kurs / FCF (TTM) | 319.55-Jahres-Durchschnitt ≈-10.0 | ≈-10.0 | · | · | |
| Kurs / Cashflow (TTM) | 314.65-Jahres-Durchschnitt ≈-10.2 | ≈-10.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 36.55-Jahres-Durchschnitt ≈10.9 | ≈10.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ANAB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 17.6%5-Jahres-Durchschnitt ≈-573.4% | ≈-573.4% | -135.5% | Im Einklang | |
| EBITDA-Marge (TTM) | 17.8%5-Jahres-Durchschnitt ≈-570.4% | ≈-570.4% | -135.0% | Im Einklang | |
| Vorgewinnmarge (TTM) | -11.5%5-Jahres-Durchschnitt ≈-613.8% | ≈-613.8% | -206.8% | Im Einklang | |
| Nettogewinnmarge (TTM) | -11.5%5-Jahres-Durchschnitt ≈-613.9% | ≈-613.9% | -206.9% | Im Einklang | |
| ROA (TTM) | -7.1%5-Jahres-Durchschnitt ≈-23.3% | ≈-23.3% | -37.9% | Spitzenklasse | |
| ROE (TTM) | -114.6%5-Jahres-Durchschnitt ≈-101.8% | ≈-101.8% | -51.2% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ANAB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 7.65-Jahres-Durchschnitt ≈18.0 | ≈18.0 | 11.1 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ANAB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 157.0%5-Jahres-Durchschnitt ≈111.3% | ≈111.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 183.6%5-Jahres-Durchschnitt ≈52.6% | ≈52.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 25.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ANAB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$2.3M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
12.1%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Sep 11, 2026 | $0.07 | $0.00 | — |
| 31. März 2026 | Mai 7, 2026 | $-1.84 | $-0.62 | -198.7% |
| 31. Dezember 2025 | $1.58 | $0.96 | 65.0% | |
| 30. September 2025 | $0.52 | $-1.47 | 135.4% | |
| 30. Juni 2025 | $-1.34 | $-1.57 | 14.8% | |
| 31. März 2025 | $-1.28 | $-1.28 | -0.12% | |
| 31. Dezember 2024 | $-0.72 | $-1.65 | 56.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $235M | $91M | $17M | $10M | $63M | $75M | $8M | $5M | $10M | $17M | |
| R&D Expense | · | · | · | $89M | $98M | $80M | $99M | $56M | $29M | $15M | |
| SG&A Expense | $51M | $42M | $42M | $37M | $21M | $19M | $16M | $16M | $9M | $4M | |
| Operating Expenses | $187M | $206M | $182M | $125M | $120M | $99M | $115M | $72M | $39M | $20M | |
| Operating Income | $48M | $-115M | $-164M | $-115M | $-57M | $-24M | $-107M | $-67M | $-29M | $-3M | |
| Interest Expense | · | · | · | · | $0 | $0 | $1M | $2M | $2M | $458.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $127.0K | |
| Other Non-op | $5M | $14.0K | $-2.0K | $12.0K | $37.0K | $-11.0K | $1.0K | $-159.0K | $229.0K | $-147.0K | |
| Pretax Income | $-13M | $-145M | $-164M | $-129M | $-58M | $-20M | $-97M | $-62M | $-30M | $-4M | |
| Income Tax | $164.0K | $3.0K | $-4.0K | $24.0K | $0 | $0 | $-152.0K | $-192.0K | $0 | $0 | |
| Net Income | $-13M | $-145M | $-164M | $-129M | $-58M | $-20M | $-97M | $-62M | $-30M | $-4M | |
| EPS (Basic) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 | |
| EPS (Diluted) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 | |
| Shares (Basic) | 28,758,000 | 28,382,000 | 26,924,000 | 28,165,000 | 27,431,000 | 27,302,000 | 27,059,000 | · | · | · | |
| Shares (Diluted) | 28,758,000 | 28,382,000 | 26,924,000 | 28,165,000 | 27,431,000 | 27,302,000 | 27,059,000 | · | · | · | |
| EBITDA | · | $-114M | $-164M | $-114M | $-56M | $-23M | $-107M | $-66M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $238M | $123M | $36M | $71M | $496M | $250M | $171M | $114M | $81M | $51M | |
| Receivables | $34M | $41M | $7M | $1M | $876.0K | $0 | $0 | $0 | $0 | $1M | |
| Prepaid Expense | $5M | $6M | $9M | $5M | $5M | $3M | $4M | $7M | $3M | $2M | |
| Current Assets | $350M | $432M | $407M | $447M | $554M | $397M | $378M | $434M | $253M | $58M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $665.0K | $471.0K | |
| PP&E (Gross) | $9M | $8M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | |
| Accum. Depreciation | $7M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Other Non-current Assets | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $258.0K | $1M | $148.0K | $46.0K | · | |
| Total Assets | $364M | $484M | $452M | $610M | $643M | $417M | $435M | $509M | $329M | $62M | |
| Accounts Payable | $4M | $4M | $5M | $3M | $2M | $4M | $16M | $5M | $2M | $2M | |
| Accrued Liabilities | $33M | $40M | $31M | $22M | $13M | $15M | $11M | $9M | $5M | $3M | |
| Short-term Debt | · | · | · | · | · | $0 | $1M | $8M | $7M | $0 | |
| Current Liabilities | $39M | $45M | $37M | $26M | $16M | $20M | $30M | $22M | $14M | $6M | |
| Capital Leases | $12M | $14M | $16M | $18M | $19M | $0 | $654.0K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $0 | $654.0K | $796.0K | · | · | |
| Total Debt | · | · | · | · | · | $0 | $1M | $8M | · | · | |
| Common Stock | $28.0K | $30.0K | $27.0K | $29.0K | $28.0K | $27.0K | $27.0K | $27.0K | $24.0K | $3.0K | |
| Paid-in Capital | $810M | $830M | $703M | $718M | $679M | $661M | $649M | $633M | $393M | $17M | |
| Retained Earnings | $-773M | $-759M | $-614M | $-450M | $-322M | $-264M | $-244M | $-147M | $-85M | $-55M | |
| AOCI | $-24.0K | $305.0K | $-797.0K | $-5M | $-422.0K | $-4.0K | $338.0K | $-223.0K | $-426.0K | $0 | |
| Stockholders' Equity | $37M | $71M | $88M | $262M | $356M | $397M | $405M | $486M | $308M | $-38M | |
| Liabilities + Equity | $364M | $484M | $452M | $610M | $643M | $417M | $435M | $509M | $329M | $62M | |
| Shares Outstanding | 28,019,000 | 30,473,000 | 26,597,000 | 28,513,000 | 27,647,000 | 27,356,000 | 27,255,000 | 26,922,000 | 23,791,000 | 2,651,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $559.0K | $606.0K | $652.0K | $675.0K | $619.0K | $559.0K | $514.0K | $315.0K | $183.0K | $233.0K | |
| Stock-based Comp | $36M | $34M | $33M | $27M | $15M | · | · | · | $4M | $1M | |
| Other Non-cash | · | $-25M | $9M | $54M | $11M | $5M | $27M | $13M | · | · | |
| Operating Cash Flow | $20M | $-135M | $-121M | $-74M | $-46M | $-14M | $-70M | $-49M | $-19M | $-9M | |
| CapEx | $87.0K | $358.0K | $807.0K | $358.0K | $1M | $569.0K | $805.0K | $1M | $290.0K | $50.0K | |
| Investing Cash Flow | $228M | $95M | $145M | $-395M | $39M | $94M | $131M | $-142M | $-243M | $-50.0K | |
| Stock Issued | $14M | $6M | $2M | $12M | $3M | $496.0K | $3M | $227M | $293M | $0 | |
| Stock Repurchased | $69M | $456.0K | $50M | $0 | $0 | · | · | $0 | $0 | $1.0K | |
| Net Stock Activity | · | $6M | $-48M | $12M | $3M | $0 | $0 | $227M | · | · | |
| Financing Cash Flow | $-133M | $127M | $-59M | $44M | $252M | $-879.0K | $-4M | $223M | $292M | $9M | |
| Net Change in Cash | $115M | $87M | $-35M | $-424M | $245M | $79M | $57M | $32M | · | · | |
| Free Cash Flow | · | $-136M | $-122M | $-74M | $-47M | $-15M | $-70M | $-50M | · | · | |
| Levered FCF | · | · | · | · | $-47M | $-15M | $-71M | $-51M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -125.9% | -958.3% | -1119.4% | -89.9% | -31.8% | -1342.9% | -1334.4% | · | · | |
| Net Margin | · | -159.1% | -953.7% | -1251.3% | -91.5% | -26.6% | -1216.7% | -1233.1% | · | · | |
| Pretax Margin | · | -159.1% | -953.7% | -1251.1% | -91.5% | -26.6% | -1218.6% | -1237.0% | · | · | |
| EBITDA Margin | · | -125.3% | -954.5% | -1112.9% | -88.9% | -31.1% | -1336.5% | -1328.1% | · | · | |
| ROA | · | -31.0% | -30.8% | -20.5% | -10.9% | -4.7% | -20.6% | -14.7% | · | · | |
| ROE | · | -187.1% | -157.0% | -47.7% | -15.6% | -5.3% | -23.6% | -12.5% | · | · | |
| ROIC | · | -162.2% | -186.6% | -43.9% | -15.9% | -6.0% | -26.4% | -13.5% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 9.5 | 10.9 | 17.2 | 34.4 | 20.0 | 12.8 | 19.9 | · | · | |
| Quick Ratio | · | 3.6 | 1.1 | 2.8 | 30.8 | 12.6 | 5.8 | 5.2 | · | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | -103.2 | -40.4 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | · | 3.8 | 4.1 | 9.0 | 144.2 | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.33 | $3.31 | $9.19 | $12.89 | $14.50 | $14.86 | $18.07 | · | · | |
| Revenue / Share | · | $3.22 | $0.64 | $0.37 | $2.30 | · | · | · | · | · | |
| Cash Flow / Share | · | $-4.77 | $-4.49 | $-2.61 | $-1.67 | · | · | · | · | · | |
| Cash / Share | · | $4.04 | $1.35 | $2.50 | $17.93 | $9.16 | $6.27 | $4.22 | · | · | |
| EPS (TTM) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 157.0% | 432.0% | 66.8% | -83.7% | -15.8% | · | · | · | · | · | |
| Revenue CAGR 3Y | 183.6% | 13.1% | -38.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 25.6% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $235M | $91M | $17M | $10M | $63M | $75M | $8M | $5M | $10M | $17M | |
| Net Income TTM | $-13M | $-145M | $-164M | $-129M | $-58M | $-20M | $-97M | $-62M | $-30M | $-4M | |
| Market Cap | · | $403M | $570M | $884M | $961M | $588M | $443M | $1.72B | · | · | |
| Enterprise Value | · | · | · | · | · | $338M | $273M | $1.61B | · | · | |
| P/E | -105.4 | -2.6 | -3.5 | -6.8 | -16.5 | -29.5 | -4.5 | -25.5 | -66.3 | · | |
| P/S | · | 4.4 | 33.2 | 85.9 | 15.2 | 7.8 | 55.4 | 343.5 | · | · | |
| P/B | · | 5.7 | 6.5 | 3.4 | 2.7 | 1.5 | 1.1 | 3.5 | · | · | |
| P / Tangible Book | 36.5 | 5.7 | 6.5 | 3.4 | 2.7 | 1.5 | · | · | · | · | |
| P / Cash Flow | · | -3.0 | -4.7 | -12.0 | -20.9 | -41.5 | -6.4 | -35.4 | · | · | |
| P / FCF | · | -3.0 | -4.7 | -11.9 | -20.3 | -39.9 | -6.3 | -34.6 | · | · | |
| EV / EBITDA | · | · | · | · | · | -14.5 | -2.6 | -24.3 | · | · | |
| EV / FCF | · | · | · | · | · | -22.9 | -3.9 | -32.5 | · | · | |
| EV / Revenue | · | · | · | · | · | 4.5 | 34.2 | 322.3 | · | · | |
| Earnings Yield | -0.95% | -38.7% | -28.4% | -14.8% | -6.1% | -3.4% | -22.1% | -3.9% | -1.5% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26M | $108M | $76M | $22M | $28M | $43M | $30M | $11M | $7M | $9M | $3M | $3M | $1M | $1M | $1M | $970.0K | |
| R&D Expense | · | · | $31M | $38M | $41M | · | $42M | $42M | $37M | · | $31M | $33M | $35M | $22M | $21M | $23M | |
| SG&A Expense | $26M | $16M | $10M | $11M | $14M | $10M | $11M | $9M | $12M | $10M | $10M | $11M | $11M | $9M | $8M | $10M | |
| Operating Expenses | $60M | $41M | $42M | $48M | $55M | $53M | $53M | $51M | $49M | $51M | $41M | $44M | $46M | $31M | $29M | $33M | |
| Operating Income | $-35M | $67M | $35M | $-26M | $-28M | $-10M | $-23M | $-40M | $-42M | $-42M | $-38M | $-40M | $-44M | $-30M | $-28M | $-32M | |
| Other Non-op | $-1.0K | $-3.0K | $0 | $4M | $2M | $21.0K | $-5.0K | $0 | $-2.0K | $-2.0K | $1.0K | $3.0K | $-4.0K | $4.0K | $6.0K | $6.0K | |
| Pretax Income | $-53M | $50M | $15M | $-39M | $-39M | $-22M | $-33M | $-47M | $-44M | $-42M | $-37M | $-40M | · | · | · | · | |
| Income Tax | $40.0K | $81.0K | $0 | $39.0K | $44.0K | $-6.0K | $0 | $9.0K | $0 | $-4.0K | $0 | · | · | · | · | · | |
| Net Income | $-53M | $50M | $15M | $-39M | $-39M | $-22M | $-33M | $-47M | $-44M | $-42M | $-37M | $-40M | $-44M | $-34M | $-33M | $-36M | |
| EPS (Basic) | $-1.84 | $1.62 | $0.54 | $-1.34 | $-1.28 | $-0.63 | $-1.14 | $-1.71 | $-1.64 | $-1.59 | $-1.41 | $-1.50 | $-1.58 | $-1.18 | $-1.15 | $-1.31 | |
| EPS (Diluted) | $-1.84 | $1.64 | $0.52 | $-1.34 | $-1.28 | $-0.63 | $-1.14 | $-1.71 | $-1.64 | $-1.59 | $-1.41 | $-1.50 | $-1.58 | $-1.18 | $-1.15 | $-1.31 | |
| Shares (Basic) | 28,691,000 | · | 27,833,000 | 28,810,000 | 30,644,000 | · | 28,893,000 | 27,356,000 | 26,801,000 | · | 26,546,000 | 26,629,000 | 27,953,000 | 28,289,000 | 28,204,000 | 27,713,000 | |
| Shares (Diluted) | 28,691,000 | · | 29,018,000 | 28,810,000 | 30,644,000 | · | 28,893,000 | 27,356,000 | 26,801,000 | · | 26,546,000 | 26,629,000 | 27,953,000 | 28,289,000 | 28,204,000 | 27,713,000 | |
| EBITDA | $-35M | · | $35M | $-26M | $-27M | · | $-23M | $-40M | $-42M | · | $-38M | $-40M | $-44M | $-30M | $-28M | $-32M |
Bilanz
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $248M | $238M | $110M | $44M | $99M | $123M | $192M | $72M | $54M | · | $26M | $35M | $95M | $59M | $72M | $166M | |
| Receivables | $26M | $34M | $76M | $21M | $18M | $41M | $12M | $9M | $7M | · | $3M | $3M | $2M | $1M | $1M | $921.0K | |
| Prepaid Expense | $4M | $5M | $6M | $5M | $5M | $6M | $6M | $8M | $11M | · | $12M | $6M | $4M | $6M | $10M | $6M | |
| Current Assets | $316M | $350M | $331M | $292M | $363M | $432M | $449M | $367M | $372M | · | $428M | $439M | $437M | $450M | $453M | $512M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $6M | · | $6M | $6M | $6M | $5M | $5M | $5M | |
| Other Non-current Assets | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | · | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | |
| Total Assets | $330M | $364M | $353M | $335M | $422M | $484M | $493M | $427M | $406M | · | $487M | $517M | $552M | $619M | $604M | $625M | |
| Accounts Payable | $8M | $4M | $3M | $3M | $6M | $4M | $4M | $5M | $5M | · | $7M | $5M | $3M | $3M | $2M | $2M | |
| Accrued Liabilities | $32M | $33M | $33M | $30M | $36M | $40M | $38M | $34M | $26M | · | $31M | $35M | $31M | $16M | $17M | $16M | |
| Current Liabilities | $42M | $39M | $38M | $36M | $44M | $45M | $44M | $40M | $32M | · | $39M | $42M | $36M | $21M | $20M | $20M | |
| Capital Leases | $11M | $12M | $13M | $13M | $14M | $14M | $15M | $15M | $16M | · | $16M | $17M | $17M | $18M | $19M | $19M | |
| Common Stock | $29.0K | $28.0K | $28.0K | $28.0K | $30.0K | $30.0K | $30.0K | $27.0K | $27.0K | · | $27.0K | $27.0K | $27.0K | $28.0K | $28.0K | $28.0K | |
| Paid-in Capital | $838M | $810M | $793M | $793M | $832M | $830M | $821M | $715M | $706M | · | $695M | $687M | $689M | $708M | $699M | $691M | |
| Retained Earnings | $-825M | $-773M | $-822M | $-837M | $-799M | $-759M | $-738M | $-705M | $-658M | · | $-572M | $-535M | $-495M | $-424M | $-391M | $-358M | |
| AOCI | $-146.0K | $-24.0K | $47.0K | $-6.0K | $161.0K | $305.0K | $759.0K | $-415.0K | $-624.0K | · | $-2M | $-4M | $-3M | $-6M | $-4M | $-2M | |
| Stockholders' Equity | $13M | $37M | $-29M | $-45M | $34M | $71M | $84M | $10M | $48M | $88M | $120M | $148M | $191M | $278M | $304M | $331M | |
| Liabilities + Equity | $330M | $364M | $353M | $335M | $422M | $484M | $493M | $427M | $406M | · | $487M | $517M | $552M | $619M | $604M | $625M | |
| Shares Outstanding | 29,031,000 | 28,019,000 | 27,575,000 | 27,973,000 | 30,388,000 | 30,473,000 | 30,429,000 | 27,434,000 | 27,317,000 | 26,597,000 | 26,575,000 | 26,531,000 | 27,018,000 | 28,354,000 | 28,231,000 | 28,178,000 |
Cashflow
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $130.0K | $131.0K | $140.0K | $142.0K | $146.0K | $145.0K | $144.0K | $154.0K | $163.0K | $165.0K | $158.0K | $163.0K | $166.0K | $166.0K | $163.0K | $162.0K | |
| Stock-based Comp | $14M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $10M | $8M | $8M | $8M | $9M | $6M | $7M | $8M | |
| Other Non-cash | $13M | · | · | · | $19M | · | · | · | $-4M | · | · | · | $11M | · | · | $7M | |
| Operating Cash Flow | $-26M | $98M | $-27M | $-40M | $-11M | $-67M | $-10M | $-21M | $-37M | $-34M | $-36M | $-25M | $-25M | $-18M | $-24M | $-21M | |
| CapEx | $17.0K | $1.0K | $12.0K | $39.0K | $35.0K | $263.0K | $35.0K | $33.0K | $27.0K | $280.0K | $162.0K | $190.0K | $175.0K | $50.0K | $78.0K | $55.0K | |
| Investing Cash Flow | $35M | $74M | $103M | $36M | $15M | $-29M | $59M | $-2M | $69M | $49M | $31M | $-20M | $85M | $-32M | $-71M | $-313M | |
| Stock Issued | $14M | $12M | $336.0K | $1M | $290.0K | $555.0K | $4M | $979.0K | $811.0K | $264.0K | $160.0K | $783.0K | $1M | $3M | $865.0K | $5M | |
| Stock Repurchased | $0 | $3M | $10M | $51M | $4M | $456.0K | $0 | $0 | $0 | $0 | $0 | $12M | $38M | $0 | $0 | $0 | |
| Net Stock Activity | $14M | · | · | · | $-4M | · | · | · | $811.0K | · | · | · | $-36M | · | · | $5M | |
| Financing Cash Flow | $1M | $-43M | $-10M | $-50M | $-29M | $28M | $71M | $42M | $-14M | $-5M | $-3M | $-13M | $-38M | $37M | $432.0K | $5M | |
| Net Change in Cash | $10M | $128M | $66M | $-54M | $-24M | $-69M | $120M | $18M | $18M | $10M | $-9M | $-59M | $23M | $-13M | $-95M | $-329M | |
| Free Cash Flow | $-26M | · | · | · | $-11M | · | · | · | $-37M | · | · | · | $-25M | · | · | $-21M |
Rentabilität
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -135.5% | · | 45.5% | -117.5% | -99.2% | · | -75.8% | -367.5% | -587.8% | · | -1137.2% | -1160.2% | -3231.5% | -2291.8% | -2286.1% | -3273.1% | |
| Net Margin | -206.9% | · | 19.8% | -173.5% | -141.6% | · | -109.4% | -425.3% | -612.0% | · | -1124.4% | -1151.6% | -3220.9% | -2591.0% | -2677.1% | -3737.6% | |
| Pretax Margin | -206.8% | · | 19.8% | -173.3% | -141.5% | · | -109.4% | -425.2% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -135.0% | · | 45.5% | -117.5% | -98.6% | · | -75.8% | -367.5% | -585.6% | · | -1137.2% | -1160.2% | -3219.4% | -2291.8% | -2286.1% | -3256.4% | |
| ROA | -14.1% | · | 3.6% | -10.1% | -9.5% | · | -6.7% | -9.9% | -9.2% | · | -6.8% | -7.1% | -7.5% | -6.4% | -6.3% | -7.1% | |
| ROE | -226.1% | · | 55.0% | 221.7% | -96.2% | · | -32.1% | -58.9% | -36.8% | · | -18.8% | -17.6% | -17.0% | -10.1% | -9.4% | -10.2% | |
| ROIC | -271.9% | · | -118.0% | 58.6% | -81.0% | · | -27.0% | -408.2% | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | · | 8.7 | 8.2 | 8.2 | · | 10.2 | 9.1 | 11.5 | · | 10.9 | 10.5 | 12.2 | 21.4 | 22.8 | 25.9 | |
| Quick Ratio | 6.6 | · | 4.9 | 1.8 | 2.6 | · | 4.6 | 2.0 | 1.9 | · | 0.8 | 0.9 | 2.7 | 2.8 | 3.7 | 8.5 |
Effizienz
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.2 | · | 1.7 | 1.5 | 2.2 | · | 3.9 | 1.8 | 1.7 | · | 1.5 | 1.6 | 1.1 | 1.3 | 1.5 | 0.9 |
Pro Aktie
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.44 | · | $-1.07 | $-1.60 | $1.12 | · | $2.77 | $0.36 | $1.75 | · | $4.53 | $5.60 | $7.07 | $9.79 | $10.78 | $11.74 | |
| Revenue / Share | $0.89 | · | $2.63 | $0.77 | $0.91 | · | $1.04 | $0.40 | $0.27 | · | $0.12 | $0.13 | $0.05 | $0.05 | $0.04 | $0.04 | |
| Cash Flow / Share | $-0.90 | · | · | · | $-0.35 | · | · | · | $-1.39 | · | · | · | $-0.88 | · | · | $-0.76 | |
| Cash / Share | $8.56 | · | $3.98 | $1.58 | $3.25 | · | $6.30 | $2.62 | $1.97 | · | $0.99 | $1.33 | $3.50 | $2.06 | $2.54 | $5.91 | |
| EPS (TTM) | $-1.02 | · | $-2.73 | $-4.39 | $-4.76 | · | $-6.08 | $-6.35 | $-6.14 | · | $-5.42 | $-5.19 | $-4.84 | $-4.83 | $-3.89 | $-2.76 |
Bewertung (TTM)
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $232M | · | $169M | $123M | $112M | · | $57M | $30M | $23M | · | $15M | $13M | $11M | $4M | $24M | $53M | |
| Net Income TTM | $-27M | · | $-85M | $-133M | $-141M | · | $-166M | $-170M | $-163M | · | $-148M | $-144M | $-137M | $-135M | $-108M | $-76M | |
| Market Cap | $1.61B | · | $844M | $621M | $565M | · | $1.02B | $687M | $615M | · | $477M | $540M | $588M | $723M | $573M | $697M | |
| P/E | -54.4 | · | -11.2 | -5.1 | -3.9 | · | -5.5 | -3.9 | -3.7 | · | -3.3 | -3.9 | -4.5 | -5.3 | -5.2 | -9.0 | |
| P/S | 6.9 | · | 5.0 | 5.0 | 5.0 | · | 17.8 | 22.6 | 26.8 | · | 31.9 | 41.7 | 55.0 | 161.1 | 23.8 | 13.2 | |
| P/B | 126.3 | · | -28.7 | -13.9 | 16.6 | · | 12.1 | 69.6 | 12.9 | · | 4.0 | 3.6 | 3.1 | 2.6 | 1.9 | 2.1 | |
| P / Tangible Book | 126.3 | · | · | · | 16.6 | · | 12.1 | 69.6 | 12.9 | · | 4.0 | 3.6 | 3.1 | 2.6 | 1.9 | 2.1 | |
| P / Cash Flow | -62.1 | · | · | · | -52.8 | · | · | · | -16.5 | · | · | · | -23.9 | · | · | -33.2 | |
| Earnings Yield | -1.8% | · | -8.9% | -19.8% | -25.6% | · | -18.1% | -25.3% | -27.3% | · | -30.2% | -25.5% | -22.2% | -18.9% | -19.2% | -11.2% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $235M | $91M | $17M | $10M | $63M |
| Betriebsgewinnmarge % | · | -125.9% | -958.3% | -1119.4% | -89.9% |
| Nettoergebnis | $-13M | $-145M | $-164M | $-129M | $-58M |
| Verwässerte EPS | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | · | 9.5 | 10.9 | 17.2 | 34.4 |
| Quick Ratio | · | 3.6 | 1.1 | 2.8 | 30.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-136M | $-122M | $-74M | $-47M |
Institutionelle Eigentümer (13F) 226 Einreicher · $2.1B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
226
Gehaltener Wert
$2.1B
Neue Positionen
47
Geschlossene Positionen
34
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 47 (-6 vs. Vorquartal) | 34 (+15 vs. Vorquartal) | 74 (+18 vs. Vorquartal) | 63 (-8 vs. Vorquartal) | +2.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $531.906.345 | 7.880.094 | 24,81% | Aktien |
| BlackRock, Inc. | $124.473.310 | 1.844.049 | 5,81% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $89.834.333 | 1.330.879 | 4,19% | Aktien |
| STATE STREET CORP | $86.818.095 | 1.286.194 | 4,05% | Aktien |
| VANGUARD GROUP INC | $74.854.914 | 1.544.037 | 3,49% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $61.170.728 | 906.233 | 2,85% | Aktien |
| Affinity Asset Advisors, LLC | $55.762.358 | 826.109 | 2,60% | Aktien |
| Sanofi | $55.479.398 | 821.917 | 2,59% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $54.493.830 | 807.316 | 2,54% | Aktien |
| Woodline Partners LP | $48.398.445 | 717.014 | 2,26% | Aktien |
| 683 Capital Management, LLC | $44.550.001 | 660.000 | 2,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $43.064.353 | 637.873 | 2,01% | Aktien |
| Palo Alto Investors LP | $40.735.508 | 603.489 | 1,90% | Aktien |
| GOLDMAN SACHS GROUP INC | $39.424.725 | 584.070 | 1,84% | Aktien |
| First Light Asset Management, LLC | $39.285.270 | 582.004 | 1,83% | Aktien |
| D. E. Shaw & Co., Inc. | $36.427.456 | 539.666 | 1,70% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $35.630.415 | 527.858 | 1,66% | Aktien |
| Apis Capital Advisors, LLC | $33.547.500 | 497.000 | 1,56% | Aktien |
| Sofinnova Investments, Inc. | $33.313.680 | 493.536 | 1,55% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $32.983.943 | 488.651 | 1,54% | Aktien |
| Nuveen, LLC | $28.394.821 | 420.664 | 1,32% | Aktien |
| BANK OF AMERICA CORP /DE/ | $28.202.310 | 417.812 | 1,32% | Aktien |
| CITADEL ADVISORS LLC | $26.620.178 | 394.373 | 1,24% | Aktien |
| FEDERATED HERMES, INC. | $26.437.523 | 391.667 | 1,23% | Aktien |
| Squarepoint Ops LLC | $21.900.105 | 324.446 | 1,02% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $17.752.163 | 262.995 | 0,83% | Aktien |
| FIRST TRUST ADVISORS LP | $17.481.757 | 258.989 | 0,82% | Aktien |
| MORGAN STANLEY | $17.353.682 | 257.091 | 0,81% | Aktien |
| TWO SIGMA ADVISERS, LP | $17.292.816 | 356.700 | 0,81% | Aktien |
| Coppell Advisory Solutions LLC | $16.575.695 | 3.638 | 0,77% | Aktien |
| FMR LLC | $16.234.486 | 240.511 | 0,76% | Aktien |
| Qube Research & Technologies Ltd | $15.442.448 | 228.777 | 0,72% | Aktien |
| HSBC HOLDINGS PLC | $14.928.261 | 216.949 | 0,70% | Aktien |
| Empowered Funds, LLC | $13.905.675 | 206.010 | 0,65% | Aktien |
| NORTHERN TRUST CORP | $13.686.773 | 202.767 | 0,64% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.655.588 | 202.305 | 0,64% | Aktien |
| Invesco Ltd. | $13.638.781 | 202.056 | 0,64% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $12.517.471 | 185.444 | 0,58% | Aktien |
| Greenhaven Road Investment Management, L.P. | $11.546.483 | 171.059 | 0,54% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $11.422.823 | 169.227 | 0,53% | Aktien |
| MACKENZIE FINANCIAL CORP | $10.191.083 | 150.979 | 0,48% | Aktien |
| UBS Group AG | $9.911.161 | 146.832 | 0,46% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $9.903.870 | 146.724 | 0,46% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $9.519.256 | 141.026 | 0,44% | Aktien |
| Ensign Peak Advisors, Inc | $7.228.980 | 107.096 | 0,34% | Aktien |
| FRANKLIN RESOURCES INC | $7.219.058 | 106.949 | 0,34% | Aktien |
| CITIGROUP INC | $6.690.195 | 99.114 | 0,31% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $6.327.000 | 93.732 | 0,30% | Aktien |
| PRUDENTIAL FINANCIAL INC | $5.800.410 | 85.932 | 0,27% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $5.666.085 | 83.942 | 0,26% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×5 Einreichungen | 16. August 2024 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Frazier Healthcare V, L.P., FHM V, L.P., FHM V, L.L.C., Frazier Healthcare VII, L.P., Frazier Healthcare VII-A, L.P., FHM VII, L.P., FHM VII, L.L.C., James N. Topper, Patrick J. Heron, Alan Frazier, Nader Naini, Nathan Every, Brian Morfitt ×5 Einreichungen | 18. November 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 7 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Faga | President, CEO | 12. März 2026 A | 495.965 | 0 | 13 | $-2.805.094 |
| Hamza Suria | President, CEO | 10. Februar 2022 A | 68.600 | 0 | 0 | $0 |
| Christopher M. Murphy | Chief Financial Officer | 11. Mai 2026 A | · | 0 | 0 | $0 |
| Dominic Piscitelli | Chief Financial Officer | 8. Februar 2019 A | 0 | 0 | 0 | $0 |
| Lizzul Paul F. | Chief Medical Officer | 12. März 2026 A | 42.088 | 0 | 4 | $-521.527 |
| Marco Londei | Chief Medical Officer | 6. Dezember 2019 A | 68.579 | 0 | 0 | $0 |
| Matthew Moyle | Chief Scientific Officer | 24. Februar 2017 A | · | 0 | 0 | $0 |
| Hollings Renton | Direktor | 1. Oktober 2026 M | 10.995 | 0 | 1 | $-249.350 |
| John A Orwin | Direktor | 15. September 2026 M | 17.995 | 0 | 0 | $0 |
| John P. Schmid | Direktor | 15. Juni 2026 M | 37.652 | 0 | 3 | $-1.158.467 |
| Owen Hughes | Direktor | 11. Mai 2026 A | · | 0 | 0 | $0 |
| Susannah Gray | Direktor | 27. April 2026 A | · | 0 | 0 | $0 |
| Magda Marquet | Direktor | 15. Januar 2026 M | 9.930 | 0 | 2 | $-530.569 |
| Anthony J. Ware | Direktor | 6. Januar 2026 A | 9.630 | 0 | 1 | $-193.362 |
| Rita Jain | Direktor | 6. Januar 2026 A | 11.864 | 0 | 0 | $0 |
| Dennis M Fenton | Direktor | 6. Januar 2026 A | 4.965 | 0 | 0 | $0 |
| Nicholas Lydon | Direktor | 8. Februar 2019 A | 271.106 | 0 | 0 | $0 |
| James A Schoeneck | Direktor | 2. Februar 2018 A | · | 0 | 0 | $0 |
| Carol Giltner Gallagher | Direktor | 2. Februar 2018 A | 64.296 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10%-Eigentümer | 14. August 2024 P | 7.794.996 | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 21. August 2017 S | 1.936.604 | 0 | 0 | $0 |
| Eric J Loumeau | · | 11. Februar 2026 M | 12.835 | 0 | 12 | $-2.744.508 |
| Dennis Mulroy | · | 7. Januar 2026 M | 21.852 | 0 | 6 | $-1.549.401 |
| Laura Hamill | · | 6. Januar 2023 A | · | 0 | 0 | $0 |
| James N. Topper | · | 6. Januar 2023 A | 80.812 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 33 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 2,38% | 201.034 SH | 1. Oktober 2026 | Täglich |
| BRNY · EA Series Trust | 1,14% | 123.969 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,64% | 5.543 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,53% | 130.011 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,47% | 24.411 SH | 1. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,29% | 26.728 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 64.617 NS | 31. Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,21% | 1.384 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 50.791 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,11% | 208.149 SH | 11. September 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 11.777 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 2.103 SH | 1. Oktober 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 44.946 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,08% | 365 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 21.182 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,07% | 185.565 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 113.787 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,04% | 510.083 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 14.019 SH | 30. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 64.608 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 236.970 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 47.570 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 7.513 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1.349 SH | 10. September 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 1.822 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 7.466 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 29.415 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 6.052 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 648.146 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.580 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 826 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 2.912 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 2.453 SH | 1. September 2026 | Täglich |
ANAB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 17 Analysten
KAUF
Median-Ziel
$79.50
+63,8%
6 35,3%
Starker Kauf
10 58,8%
Kauf
1 5,9%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-10-01Mittelwert-Ziel $87.25 +79,8%
← Unter allen Zielen
Aktueller Preis $48.53
Tief$60.00
Mittelwert$87.25
Hoch$140.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ANAB | · | -105.4 | 157.0% | · | · | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
| COAG | · | · | · | · | · | · |
| KLRA | · | · | · | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Mai 12, 2026